CHI3L1 and in situ carcinoma: However, such a correlation has not been observed between serum CHI3L1 levels and conversion from CIS to CDMS, as CHI3L1 levels in serum for both CIS patients (converted and non-converted to MS) were similar to each other and significantly higher than controls [78].